Primary Hepatic Amyloidosis with Severe Cholestasis: A Case Report
Abstract
Despite the fact that hepatic involvement is frequently seen in systemic primary amyloidosis, major hepatic symptoms as primary manifestation and severe impaired liver function are rare. Herein, we report a 38-year-old woman with primary hepatic amyloidosis, and severe portal hypertension. The patient had ascites and markedly elevated alkaline phosphatase level at presentation. She had a rapid downhill course resulting in death. In case of an unexplained intrahepatic cholestasis or portal hypertension the possibility of amyloidosis should be considered and a Congo red staining should be performed.
Keywords
Full Text:
PDFReferences
Gertz M, Kyle R. Hepatic amyloidosis: Clinical appraisal in 77 patients. Hepatology 1997;25:118-21.
Greipp PR. Amyloidosis (AL): An approach to early diagnosis. Arch Intern Med 1984;144:2145-6.
Levy M, Fryd CH, Eliakim M. Intrahepatic obstructive jaundice due to amyloidosis of the liver: A case report and review of the literature. Gastroenterology 1971;61:234-8.
GertzMA, KyleRA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): The natural history in 80 patients. Am J Med 1988;85:73-80.
Shin YM. Hepatic amyloidosis. Korean J Hepatol 2011;17:80-3.
Gertz M. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment. Am J Hematol 2014;89:1132-40.
Rubinow A, Koff R, Cohen A. Severe intrahepatic cholestasis in primary amyloidosis. A report of four cases and review of the literature. Am J Med 1978;64:937-46.
Melkebeke P, Vandepitte J, Hannon R, Fevery J. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver. Digestion 1980;20:351-7.
Rubio P, Farrell E, Lehane D. Primary liver amyloidosis producing obstructive jaundice. South Med J 1982;72:891-2.
Cox R. Amyloidosis of the liver causing jaundice. Postgrad Med J 1982;58:1192-3.
Melato M, Manconi R, Magris D, Morassi P, Benussi D, Tiribelli C. Different morphologic aspects and clinical features in massive hepatic amyloidosis. Digestion 1984;29:138-45.
Finkelstein S, Fornasier V, Pruzanski W. Intrahepatic cholestasis with predominant pericentral deposition in systemic amyloidosis. Hum Pathol 1981;12:470-2.
Konikoff R, Mor C, Stem S, Shaklai M, Halevy J, Theodor E. Cholestasis and liver failure with lambda-AL amyloidosis. Gut 1987;28:903-6.
Hoffman N, Stein B, Davidan M, Rosenthal W. Hepatic amyloidosis presenting as severe intrahepatic cholestasis: A case report and review of the literature. Am J Gastroenterol 1988;83:783-5.
Peters RA, Koukoulis G, Gimson A, Portmann B, Westaby D, Williams R. Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut 1994;35:1322-5.
Levy M, Pollack A, Lender M. The liver in amyloidosis. Digestion 1974;10:40-51.
Gregg J, Herskovic T, Bartholomew L. Ascites in systemic amyloidosis. Arch Intern Med 1965;116:605-10.
Podolsky DK. Infiltrative, genetic, and metabolic diseases affecting the liver. In: Braunwald E, Fauci AS, Isselbacher KJ, editors. Harrison’s principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001:1766-70.
Mumford AD, O’Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 2000;110:454-60.
Banypersad SM. Updates in Cardiac Amyloidosis: A Review.J Am Heart Assoc2012;10:116-21.
Kim SH, Han JK, Lee KH, Won HJ, Kim KW,Kim JS, et al. Abdominal amyloidosis: spectrum of radiological findings. ClinRadiol 2003;58:610-20.
Mir-Madjlessi SH, Farmer RG, Hawk WA. Cholestatic jaundice associated with primary amyloidosis. Cleve Clin Q 1972;39:167-75.
Copyright (c)